Where are we now and where are we going? Multi-stakeholder perspectives on the evolution of real-world data

13 Dec 2023

Written by Joanne Walker

Artificial intelligence and machine learning Editorials Health technology assessment Market access Real-world evidence Regulation Stakeholder engagement Value assessment

Multi-stakeholder perspectives on the evolution of RWD

In a recent panel discussion facilitated by Roche, experts gathered to discuss the latest developments in real-world data (RWD), reflecting on the growing momentum for RWD and real-world evidence (RWE) to support clinical trials and decision-making, and to inform patient care – sharing their outlook for 2024. During the LinkedIn Live event, attended by almost 1200 viewers, Michelle Rohrer (Senior Vice President, Global Head of Product Development Regulatory, Roche) was joined by a global panel of experts including Arun Sujenthiran (Clinical Lead & Senior Medical Director, Flatiron Health UK), Dan Drozd (Chief Medical Officer, PicnicHealth), Shahid Hanif (Managing Director, GetReal...